{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:10:03Z","timestamp":1780668603426,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41409-026-02849-6","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:59:23Z","timestamp":1775066363000},"page":"668-676","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Twelve-year utilization and outcomes of haploidentical hematopoietic stem cell transplantation (HSCT) in the Eastern Mediterranean (EM) region: A multicenter EMBMT registry analysis"],"prefix":"10.1038","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2846-9428","authenticated-orcid":false,"given":"Jean","family":"El Cheikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6477-5286","authenticated-orcid":false,"given":"Ali","family":"Tarhini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Bazarbachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7156-2532","authenticated-orcid":false,"given":"Ibrahim","family":"Muhsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4610-6272","authenticated-orcid":false,"given":"Rawad","family":"Rihani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4681-4726","authenticated-orcid":false,"given":"Hasan","family":"Hashem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Hanbali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3287-9016","authenticated-orcid":false,"given":"Muhammad Ayaz Younus","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija","family":"Bano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riad","family":"Youniss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Gharacheh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansour","family":"Alfayez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Marei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5597-5839","authenticated-orcid":false,"given":"Salem","family":"Alshemmari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1279-7160","authenticated-orcid":false,"given":"Tariq","family":"Ghafoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4498-3865","authenticated-orcid":false,"given":"Riad","family":"El Fakih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3942-7370","authenticated-orcid":false,"given":"Mahmoud","family":"Aljurf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"2849_CR1","doi-asserted-by":"publisher","first-page":"204062072094874","DOI":"10.1177\/2040620720948743","volume":"11","author":"J Chen","year":"2020","unstructured":"Chen J, Wang H, Zhou J, Feng S. Advances in the understanding of poor graft function following allogeneic hematopoietic stem-cell transplantation. Therapeut Adv Hematol. 2020;11:2040620720948743.","journal-title":"Therapeut Adv Hematol"},{"key":"2849_CR2","doi-asserted-by":"publisher","first-page":"101255","DOI":"10.1016\/j.beha.2021.101255","volume":"34","author":"X-J Huang","year":"2021","unstructured":"Huang X-J. Overcoming graft failure after haploidentical transplantation: Is this a possibility? Best Pract Res Clin Haematol. 2021;34:101255.","journal-title":"Best Pract Res Clin Haematol"},{"key":"2849_CR3","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1172\/JCI124218","volume":"129","author":"LP Wachsmuth","year":"2019","unstructured":"Wachsmuth LP, Patterson MT, Eckhaus MA, Venzon DJ, Gress RE, Kanakry CG. Post-transplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression. J Clin Invest. 2019;129:2357\u20132373.","journal-title":"J Clin Invest"},{"key":"2849_CR4","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/ajh.23995","volume":"90","author":"M Shabbir-Moosajee","year":"2015","unstructured":"Shabbir-Moosajee M, Lombardi L, Ciurea SO. An overview of conditioning regimens for haploidentical stem cell transplantation with post-transplantation cyclophosphamide. Am J Hematol. 2015;90:541\u201348.","journal-title":"Am J Hematol"},{"key":"2849_CR5","doi-asserted-by":"crossref","unstructured":"Muhsen IN, Neiderwieser D, Garderet L, Penack O, Greinix HT, Fakih RE, et al. Patterns of Graft-Versus-Host Disease (GvHD) Prevention Practices in the Eastern Mediterranean (EM) Region: A Worldwide Network for Blood & Marrow Transplantation (WBMT) Global Study. Hematol Oncol Stem Cell Ther. 2025;18:100\u20137.","DOI":"10.4103\/hemoncstem.hemoncstem-D-25-00004"},{"key":"2849_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bmt.2008.389","volume":"43","author":"M Aljurf","year":"2009","unstructured":"Aljurf M, Zaidi SZ, Solh HE, Hussain F, Ghavamzadeh A, Mahmoud HK, et al. Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity report. Bone Marrow Transpl. 2009;43:1\u201312.","journal-title":"Bone Marrow Transpl"},{"key":"2849_CR7","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.bbmt.2011.01.019","volume":"17","author":"SO Ahmed","year":"2011","unstructured":"Ahmed SO, Ghavamzadeh A, Zaidi SZ, Baldomero H, Pasquini MC, Hussain F, et al. Trends of hematopoietic stem cell transplantation in the Eastern Mediterranean region, 1984-2007. Biol Blood Marrow Transpl. 2011;17:1352\u201361.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2849_CR8","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.hemonc.2021.09.006","volume":"16","author":"SO Ahmed","year":"2023","unstructured":"Ahmed SO, Fakih RE, Elhaddad A, Hamidieh AA, Altbakhi A, Chaudhry QN, et al. Strategic priorities for hematopoietic stem cell transplantation in the EMRO region. Hematol Oncol Stem Cell Ther. 2023;16:162\u201369.","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"2849_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.hemonc.2015.09.002","volume":"8","author":"M Aljurf","year":"2015","unstructured":"Aljurf M, Nassar A, Hamidieh AA, Elhaddad A, Hamladji R, Bazarbachi A, et al. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011\u20132012: A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT). Hematol\/Oncol Stem Cell Ther. 2015;8:167\u201375.","journal-title":"Hematol\/Oncol Stem Cell Ther"},{"key":"2849_CR10","doi-asserted-by":"crossref","unstructured":"Parvanova, I. and J. Finkelstein, Disparities in racial and ethnic representation in stem cell clinical trials, in The Importance of Health Informatics in Public Health during a Pandemic. 2020, IOS Press. p. 358-61","DOI":"10.3233\/SHTI200569"},{"key":"2849_CR11","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","volume":"123","author":"P Armand","year":"2014","unstructured":"Armand P, Kim HT, Logan BR, Wang Z, Alyea EP, Kalaycio ME, et al. Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation. Blood. 2014;123:3664\u201371.","journal-title":"Blood"},{"key":"2849_CR12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1053\/j.seminhematol.2016.01.005","volume":"53","author":"TM Robinson","year":"2016","unstructured":"Robinson TM, O\u2019Donner PV, Fuchs EJ, Luznik L. Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamide. Semin Hematol. 2016;53:90\u20137.","journal-title":"Semin Hematol"},{"key":"2849_CR13","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","volume":"15","author":"A Bacigalupo","year":"2009","unstructured":"Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transpl. 2009;15:1628\u201333.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2849_CR14","first-page":"105","volume":"3","author":"E Hatzimichael","year":"2010","unstructured":"Hatzimichael E, Tuthill M. Hematopoietic stem cell transplantation. Stem Cells Cloning. 2010;3:105\u201317.","journal-title":"Stem Cells Cloning"},{"key":"2849_CR15","first-page":"678 e1","volume":"31","author":"SJ Lee","year":"2025","unstructured":"Lee SJ, Williams KM, Sarantopoulos S, Kitko CL, Cutler C, Pidala J, et al. NIH Chronic Graft-Versus-Host Disease Consensus Conference 2025 Update. Transpl Cell Ther. 2025;31:678 e1\u2013678 e16.","journal-title":"Transpl Cell Ther"},{"key":"2849_CR16","doi-asserted-by":"publisher","first-page":"1149393","DOI":"10.3389\/frtra.2023.1149393","volume":"2","author":"J El-Cheikh","year":"2023","unstructured":"El-Cheikh J, Bidaoui G, Sharrouf L, Zahreddine A, Massoud R, Nehme R, et al. Haploidentical stem cell transplantation with post-transplant cyclophosphamide: challenges and outcomes from a tertiary care center in Lebanon. Front Transpl. 2023;2:1149393.","journal-title":"Front Transpl"},{"key":"2849_CR17","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.1182\/blood.V120.21.4159.4159","volume":"120","author":"Y Luo","year":"2012","unstructured":"Luo Y, Tan Y, Hu Y, Shi J, Zheng G, Zheng W, et al. Clinical Outcomes of Haploidentical Donor Compared with Unrelated and HLA-Matched Related Donor Hematopoietic Stem Cell Transplantation for Hematologic Malignancies. Blood. 2012;120:4159.","journal-title":"Blood"},{"key":"2849_CR18","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/ejh.13204","volume":"102","author":"S Kako","year":"2019","unstructured":"Kako S, Gomyo A, Akahoshi Y, Harada N, Kameda K, Ugai T, et al. Haploidentical transplantation using low-dose alemtuzumab: Comparison with haploidentical transplantation using low-dose thymoglobulin. Eur J Haematol. 2019;102:256\u201364.","journal-title":"Eur J Haematol"},{"key":"2849_CR19","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1007\/s00277-019-03771-2","volume":"98","author":"S Giebel","year":"2019","unstructured":"Giebel S, Boumedil A, Labopin M, Seesaghur A, Baron F, Ciceri F, et al. Trends in the use of hematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia in Europe: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Ann Hematol. 2019;98:2389\u201398.","journal-title":"Ann Hematol"},{"key":"2849_CR20","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1182\/bloodadvances.2021004192","volume":"5","author":"MM Al Malki","year":"2021","unstructured":"Al Malki MM, Tsai N, Palmer J, Mokhtari S, Tsai W, Cao T, et al. Posttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplant. Blood Adv. 2021;5:2650\u201359.","journal-title":"Blood Adv"},{"key":"2849_CR21","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41409-022-01577-x","volume":"57","author":"G Battipaglia","year":"2022","unstructured":"Battipaglia G, Galimard J, Labopin M, Raiola AM, Blaise D, Ruggeri A, et al. Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the EBMT. Bone Marrow Transpl. 2022;57:562\u201371.","journal-title":"Bone Marrow Transpl"},{"key":"2849_CR22","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41375-024-02445-x","volume":"39","author":"A Shimoni","year":"2025","unstructured":"Shimoni A, Peczynski C, Labopin M, Kulagin A, Meijer E, Cornelissen J, et al. Post-transplant cyclophosphamide separates graft-versus host disease and graft versus leukemia effects after HLA-matched stem-cell transplantation for acute myeloid leukemia. Leukemia. 2025;39:222\u20138.","journal-title":"Leukemia"},{"key":"2849_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s12026-009-8139-0","volume":"47","author":"L Luznik","year":"2010","unstructured":"Luznik L, Fuchs EJ. High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation. Immunol Res. 2010;47:65\u201377.","journal-title":"Immunol Res"},{"key":"2849_CR24","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/CCO.0b013e3280148a1a","volume":"19","author":"L Ruggeri","year":"2007","unstructured":"Ruggeri L, Mancusi A, Burchielle E, Aversa F, Martelli M, Velardi A, et al. Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. Curr Opin Oncol. 2007;19:142\u2013147.","journal-title":"Curr Opin Oncol"},{"key":"2849_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3109\/10428190009087014","volume":"38","author":"DH Fowler","year":"2000","unstructured":"Fowler DH, Gress RE. Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma. Leuk Lymphoma. 2000;38:221\u201334.","journal-title":"Leuk Lymphoma"},{"key":"2849_CR26","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/sj.bmt.1703134","volume":"28","author":"M Mohty","year":"2001","unstructured":"Mohty M, Fegeux N, Exbrayat C, Lu ZY, Legouffe E, Quittlet P, et al. Reduced intensity conditioning: enhanced graft-versus-tumor effect following dose-reduced conditioning and allogeneic transplantation for refractory lymphoid malignancies after high-dose therapy. Bone Marrow Transpl. 2001;28:335\u20139.","journal-title":"Bone Marrow Transpl"},{"key":"2849_CR27","doi-asserted-by":"publisher","first-page":"1149393","DOI":"10.3389\/frtra.2023.1149393","volume":"2","author":"J El Cheikh","year":"2023","unstructured":"El Cheikh J, Bidaoui G, Sharrouf L, Zahreddine A, Massoud R, Nehme R, et al. Haploidentical stem cell transplantation with post-transplant cyclophosphamide challenges and outcome from a tertiary care center in Lebanon. Front Transpl. 2023;2:1149393.","journal-title":"Front Transpl"},{"key":"2849_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.tmrv.2018.11.003","volume":"33","author":"A Amouzegar","year":"2019","unstructured":"Amouzegar A, Dey BR, Spitzer TR. Peripheral blood or bone marrow stem cells? Practical considerations in hematopoietic stem cell transplantation. Transfus Med Rev. 2019;33:43\u201350.","journal-title":"Transfus Med Rev"},{"key":"2849_CR29","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41409-023-01947-z","volume":"58","author":"J El Cheikh","year":"2023","unstructured":"El Cheikh J, Bidaoui G, Atoui A, Khodr T, Sharrouf L, Zahreddine A, et al. Clofarabine and total body irradiation (TBI) as conditioning regimen for allogeneic stem cell transplantation in high-risk acute leukemia patients: a two-center retrospective cohort study. Bone Marrow Transpl. 2023;58:667\u201372.","journal-title":"Bone Marrow Transpl"},{"key":"2849_CR30","first-page":"45 e1","volume":"28","author":"B George","year":"2022","unstructured":"George B, Kulkarni U, Lionel S, Devasia A, Aboobacker F, Lakshmi K, et al. Haploidentical transplantation is feasible and associated with reasonable outcomes despite major infective complications-A single center experience from India. Transpl Cell Ther. 2022;28:45 e1\u201345 e8.","journal-title":"Transpl Cell Ther"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02849-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02849-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02849-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:08:06Z","timestamp":1780664886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02849-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2849"],"URL":"https:\/\/doi.org\/10.1038\/s41409-026-02849-6","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki and all relevant institutional and national guidelines and regulations. Ethical approval for this study was obtained from the Institutional Review Board of American University of Beirut (BIO-2022-0246) and all other participating centers. The requirement for informed consent was waived by the Institutional Review Board due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}